| scholarly article | Q13442814 |
| P2093 | author name string | Qin Fu | |
| Yang K Xiang | |||
| Qingtong Wang | |||
| P2860 | cites work | R3F, a novel membrane-associated glycogen targeting subunit of protein phosphatase 1 regulates glycogen synthase in astrocytoma cells in response to glucose and extracellular signals | Q24306423 |
| Molecular basis of physiological heart growth: fundamental concepts and new players | Q27006868 | ||
| Insulin induces IRS2-dependent and GRK2-mediated β2AR internalization to attenuate βAR signaling in cardiomyocytes | Q27321553 | ||
| Paroxetine Is a Direct Inhibitor of G Protein-Coupled Receptor Kinase 2 and Increases Myocardial Contractility | Q27671474 | ||
| Glucose Transporters in Cardiac Metabolism and Hypertrophy | Q28075863 | ||
| CaMKII induces permeability transition through Drp1 phosphorylation during chronic β-AR stimulation | Q28279133 | ||
| Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act | Q28390079 | ||
| An antagonism between the AKT and beta-adrenergic signaling pathways mediated through their reciprocal effects on miR-199a-5p | Q28566847 | ||
| Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes | Q28578076 | ||
| The effect of perioperative insulin treatment on cardiodepression in mild adiposity in mice. | Q30373754 | ||
| Insulin Signaling and Heart Failure. | Q30377910 | ||
| Conformational biosensors reveal GPCR signalling from endosomes. | Q30557505 | ||
| A long lasting β1 adrenergic receptor stimulation of cAMP/protein kinase A (PKA) signal in cardiac myocytes. | Q33652136 | ||
| Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action | Q33766254 | ||
| High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injury | Q33948647 | ||
| Insulin inhibits cardiac contractility by inducing a Gi-biased β2-adrenergic signaling in hearts. | Q33959744 | ||
| Insulin receptor substrates are essential for the bioenergetic and hypertrophic response of the heart to exercise training. | Q34056611 | ||
| Insulin receptor substrate 2-mediated phosphatidylinositol 3-kinase signaling selectively inhibits glycogen synthase kinase 3β to regulate aerobic glycolysis | Q34073821 | ||
| Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure | Q34077136 | ||
| Beta(2)-adrenoceptor agonist clenbuterol reduces infarct size and myocardial apoptosis after myocardial ischaemia/reperfusion in anaesthetized rats | Q34124879 | ||
| β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway | Q34291035 | ||
| Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices | Q34514408 | ||
| G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. | Q35041039 | ||
| β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways | Q35250102 | ||
| Demonstration of a direct interaction between β2-adrenergic receptor and insulin receptor by BRET and bioinformatics | Q35425612 | ||
| Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice | Q35780290 | ||
| The evolving impact of g protein-coupled receptor kinases in cardiac health and disease | Q36000382 | ||
| Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat. | Q36042624 | ||
| Reversal of diet-induced obesity and insulin resistance by inducible genetic ablation of GRK2. | Q36100307 | ||
| Selective β2-adrenoreceptor stimulation attenuates myocardial cell death and preserves cardiac function after ischemia-reperfusion injury | Q36106686 | ||
| Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome | Q36109889 | ||
| The Role of Reactive Oxygen Species in β-Adrenergic Signaling in Cardiomyocytes from Mice with the Metabolic Syndrome | Q36209817 | ||
| Increased Energy Demand during Adrenergic Receptor Stimulation Contributes to Ca(2+) Wave Generation | Q36219325 | ||
| Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve | Q36244494 | ||
| Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway. | Q36270020 | ||
| Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery | Q36342091 | ||
| Compartmentalization of beta-adrenergic signals in cardiomyocytes | Q36384788 | ||
| Chronic Hyperinsulinemia Causes Selective Insulin Resistance and Down-regulates Uncoupling Protein 3 (UCP3) through the Activation of Sterol Regulatory Element-binding Protein (SREBP)-1 Transcription Factor in the Mouse Heart | Q36407271 | ||
| Sustained βAR Stimulation Mediates Cardiac Insulin Resistance in a PKA-Dependent Manner. | Q36415798 | ||
| Cardiac PI3K-Akt impairs insulin-stimulated glucose uptake independent of mTORC1 and GLUT4 translocation. | Q36533391 | ||
| Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction | Q36623426 | ||
| Higenamine protects ischemia/reperfusion induced cardiac injury and myocyte apoptosis through activation of β2-AR/PI3K/AKT signaling pathway | Q36635750 | ||
| Interaction of β1-adrenoceptor with RAGE mediates cardiomyopathy via CaMKII signaling | Q36661845 | ||
| β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction | Q37102508 | ||
| Hyperinsulinemia and sulfonylurea use are independently associated with left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus with suboptimal blood glucose control | Q37236614 | ||
| Comparable Attenuation of Sympathetic Nervous System Activity in Obese Subjects with Normal Glucose Tolerance, Impaired Glucose Tolerance, and Treatment Naïve Type 2 Diabetes following Equivalent Weight Loss | Q37389524 | ||
| β-Adrenergic Receptor and Insulin Resistance in the Heart | Q37551918 | ||
| Endothelin-1 suppresses insulin-stimulated Akt phosphorylation and glucose uptake via GPCR kinase 2 in skeletal muscle cells | Q37686147 | ||
| High-fat diet induces protein kinase A and G-protein receptor kinase phosphorylation of β2 -adrenergic receptor and impairs cardiac adrenergic reserve in animal hearts | Q37700020 | ||
| Taking the heart failure battle inside the cell: small molecule targeting of Gβγ subunits | Q37831634 | ||
| Reverse remodeling in heart failure--mechanisms and therapeutic opportunities | Q37964927 | ||
| Downregulation of G protein-coupled receptor kinase 2 levels enhances cardiac insulin sensitivity and switches on cardioprotective gene expression patterns | Q38304071 | ||
| Myocardial glycogen dynamics: new perspectives on disease mechanisms. | Q38353514 | ||
| Trafficking of β-Adrenergic Receptors: Implications in Intracellular Receptor Signaling | Q38521174 | ||
| TWEAK protects cardiomyocyte against apoptosis in a PI3K/AKT pathway dependent manner | Q38741719 | ||
| Carvedilol-responsive microRNAs, miR-199a-3p and -214 protect cardiomyocytes from simulated ischemia-reperfusion injury. | Q38765050 | ||
| Therapeutic synergy and complementarity for ischemia/reperfusion injury: β1-adrenergic blockade and phosphodiesterase-3 inhibition | Q38809868 | ||
| The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance | Q38920570 | ||
| Investigating mitochondrial metabolism in contracting HL-1 cardiomyocytes following hypoxia and pharmacological HIF activation identifies HIF-dependent and independent mechanisms of regulation. | Q39017440 | ||
| Novel Protein Glycan-Derived Markers of Systemic Inflammation and C-Reactive Protein in Relation to Glycemia, Insulin Resistance, and Insulin Secretion | Q39056510 | ||
| Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry | Q39133808 | ||
| Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels. | Q39198039 | ||
| p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure | Q39416345 | ||
| The antioxidant edaravone prevents cardiac dysfunction by suppressing oxidative stress in type 1 diabetic rats and in high-glucose-induced injured H9c2 cardiomyoblasts | Q39633634 | ||
| β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo | Q39992588 | ||
| Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents | Q40238333 | ||
| Prohibitin confers cytoprotection against ISO-induced hypertrophy in H9c2 cells via attenuation of oxidative stress and modulation of Akt/Gsk-3β signaling. | Q40472520 | ||
| Genetically Encoded Biosensors Reveal PKA Hyperphosphorylation on the Myofilaments in Rabbit Heart Failure. | Q40601692 | ||
| Impact of diabetes mellitus on lymphocyte GRK2 protein levels in patients with heart failure. | Q41643288 | ||
| Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. | Q42471696 | ||
| Vitamin D supplementation inhibits oxidative stress and upregulate SIRT1/AMPK/GLUT4 cascade in high glucose-treated 3T3L1 adipocytes and in adipose tissue of high fat diet-fed diabetic mice | Q42803931 | ||
| An inositol 1,4,5-triphosphate (IP3)-IP3 receptor pathway is required for insulin-stimulated glucose transporter 4 translocation and glucose uptake in cardiomyocytes | Q42946226 | ||
| Clenbuterol induces cardiac myocyte hypertrophy via paracrine signalling and fibroblast-derived IGF-1. | Q43005856 | ||
| Abnormal myocardial perfusion and risk of heart failure in patients with type 2 diabetes mellitus | Q43084955 | ||
| Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. | Q43149051 | ||
| Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. | Q43177442 | ||
| Inhibiting Insulin-Mediated β2-Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction. | Q46138106 | ||
| Markers of sympathetic nervous system activity associate with complex plasma lipids in metabolic syndrome subjects. | Q46447612 | ||
| Heart failure: mitochondrial dysfunction and oxidative stress in CHF. | Q46810978 | ||
| The heart is better protected against myocardial infarction in the fed state compared to the fasted state. | Q46980921 | ||
| Beta2-adrenergic signaling affects the phenotype of human cardiac progenitor cells through EMT modulation | Q47352347 | ||
| Association of Insulin Resistance and Glycemic Metabolic Abnormalities With LV Structure and Function in Middle Age: The CARDIA Study | Q48600860 | ||
| Rutaecarpine and evodiamine selected as β1-AR inhibitor candidates using β1-AR/CMC-offline-UPLC/MS prevent cardiac ischemia-reperfusion injury via energy modulation. | Q51741581 | ||
| High-fructose and high-fat feeding correspondingly lead to the development of lysoPC-associated apoptotic cardiomyopathy and adrenergic signaling-related cardiac hypertrophy. | Q52873528 | ||
| β-Adrenergic Responsiveness in the Type 2 Diabetic Heart: Effects on Cardiac Reserve. | Q52941415 | ||
| Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome. | Q53127227 | ||
| Common variants associated with changes in levels of circulating free fatty acids after administration of glucose-insulin-potassium (GIK) therapy in the IMMEDIATE trial. | Q53257055 | ||
| PPARγ-PI3K/AKT-NO signal pathway is involved in cardiomyocyte hypertrophy induced by high glucose and insulin. | Q53477674 | ||
| Increased cardiac remodeling in cardiac-specific Flt-1 receptor knockout mice with pressure overload. | Q53491178 | ||
| Beta-adrenergic blockade increases GLUT4 and improves glycemic control in insulin-treated diabetic Wistar rats. | Q54235446 | ||
| Glucosa-Insulin-Potassium (GIK) solution used with diabetic patients provides better recovery after coronary bypass operations. | Q54435423 | ||
| GRK2 at the control shaft of cellular metabolism. | Q54537536 | ||
| Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis | Q63966646 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 416-427 | |
| P577 | publication date | 2017-02-28 | |
| P1433 | published in | Trends in Endocrinology and Metabolism | Q15265727 |
| P1476 | title | Insulin and β Adrenergic Receptor Signaling: Crosstalk in Heart | |
| P478 | volume | 28 |
| Q90110428 | A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors |
| Q89126294 | Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management |
| Q39420123 | Diabetes-Related Cardiac Dysfunction. |
| Q58790122 | New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging |
| Q53828206 | The role of catecholamines in HIV neuropathogenesis. |
| Q92535654 | Transcriptomic Validation of the Protective Effects of Aqueous Bark Extract of Terminalia arjuna (Roxb.) on Isoproterenol-Induced Cardiac Hypertrophy in Rats |
| Q89547353 | Use of a Systematic Pharmacological Methodology to Explore the Mechanism of Shengmai Powder in Treating Diabetic Cardiomyopathy |
Search more.